Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Premarin alternative medications?Canadian pharmacy spiriva respimat?Hydroxypropyl methylcellulose phthalate market?Yupelri classification?Lumigan 0 01 generic?
See the DrugPatentWatch profile for Apriso
Current Cost of Apriso and Access Concerns The cost of Apriso, a medication used to treat Crohn's disease and ulcerative colitis, can be high, making it inaccessible to some patients. According to the pharmaceutical manufacturer, Takeda [1], the cost of Apriso varies depending on the dosage, location, and insurance coverage. In the United States, the average retail price for a month's supply of Apriso can range from approximately $1,000 to over $1,500 [2]. Insurance Coverage and Reimbursement Insurance coverage and reimbursement policies for Apriso vary among insurance providers. Some insurance plans may cover Apriso with certain limitations, such as prior authorization requirements or step therapy [3]. Patients should check with their insurance provider to determine the extent of coverage and any out-of-pocket costs. Generic and Biosimilar Options While Apriso is a branded medication, generic or biosimilar versions of the medication are not available. However, the patent for Apriso expires in 2029 [4], which may lead to the introduction of generic or biosimilar alternatives, potentially reducing costs for patients. Patient Assistance Programs Takeda offers patient assistance programs for eligible patients, which may help alleviate some of the financial burden associated with Apriso. These programs provide discounts, financial assistance, or free medication to qualifying patients [5]. Sources: [1] Takeda. (n.d.). Apriso. Retrieved from https://www.takeda.com/investors/products/apriso/ [2] GoodRx. (n.d.). Apriso Prices, Coupons & Savings Tips – GoodRx. Retrieved from https://www.goodrx.com/apriso [3] Medicare.gov. (n.d.). Apriso (mesalamine delayed-release tablets). Retrieved from https://www.medicare.gov/coverage/apriso-mesalamine-delayed-release-tablets [4] DrugPatentWatch.com. (n.d.). Apriso (mesalamine delayed-release tablets). Retrieved from https://www.drugpatentwatch.com/clinical_trials/apriso-mesalamine-delayed-release-tablets [5] Takeda. (n.d.). Patient Assistance Programs. Retrieved from https://www.takeda.com/patient-assistance-programs/
Other Questions About Apriso :